TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Updated American College of Cardiology and American Heart Association guidelines issued in March 2026 give coronary artery calcium scans a central role for some adults whose need for preventive treatment is uncertain. The scan can cost about $100, but the report argues that limited insurance coverage may keep eligible patients from getting it; it does not establish that Medicare will pay $50,000 for a heart attack or that it covers the scan.
The American College of Cardiology and American Heart Association gave coronary artery calcium scans a more central role in their March 2026 heart-disease prevention guidelines, recommending the test for some adults at borderline or intermediate risk when clinicians and patients are unsure about starting preventive treatment. The scan can cost about $100, according to the physicians writing in MedPage Today, but the source does not establish that Medicare covers it or that Medicare pays a specific amount for a heart attack.
The October 25 opinion report by cardiologists Arthur Agatston and Oren Mechanic argues that the updated guidance brings clinical recommendations closer to evidence on coronary artery calcium, or CAC, scoring. The scan detects calcified plaque in the coronary arteries and can help refine a risk estimate when standard factors leave the decision about preventive medication unresolved. The authors describe it as a roughly 10-minute scan costing about $100 and using a fraction of the radiation of a standard chest CT.
Traditional risk calculators estimate a person’s probability of cardiovascular disease using factors such as age, cholesterol, blood pressure, diabetes and smoking. A CAC scan instead looks for evidence of calcified atherosclerosis. The authors say a score of zero can support a lower risk classification, while a score above 100 can identify people who may benefit from medication and intensive lifestyle measures. The scan is a decision aid; the report does not say a score alone determines treatment.
To illustrate the approach, the authors describe a 52-year-old patient, identified by a changed name, whose calculated risk was low but whose CAC score was 220. They say the finding indicated substantial plaque for someone his age and informed a recommendation for drug treatment. This is a case example in an opinion article, not a study result or evidence that every person with a similar score will have the same outcome.
A Scan Could Change Prevention Decisions
The policy change matters because it makes imaging a more explicit option when routine risk estimates do not settle whether preventive treatment is appropriate. A scan that finds plaque may prompt a different conversation about statins or other prevention measures; a zero score may help a clinician and patient weigh whether medication is needed. The possible value lies in improving individual risk assessment, not in guaranteeing that a heart attack will be prevented.
The report also highlights a gap between clinical guidance and access. Agatston and Mechanic say doctors have often offered CAC testing mainly to patients able to pay out of pocket because coverage is limited or uncertain. Their comparison between a roughly $100 scan and a $50,000 emergency is an argument for preventive investment, not documentation of a uniform Medicare payment rate for heart attacks or proof that paying for scans would save a specified amount.
Access could shape who benefits from the new guidance. If patients face substantial out-of-pocket costs, people with fewer financial resources may be less likely to receive testing, even when a clinician considers it useful. The report proposes that artificial intelligence could identify calcification on chest CT scans already taken for other reasons, potentially bringing more patients to preventive evaluation. That prospect is not the same as a confirmed national screening program.
home blood pressure monitor upper arm clinically validated
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How CAC Reached the Guidelines
The authors say evidence for CAC scoring accumulated over more than three decades, while national prevention guidance had included the test only peripherally. They attribute the slow uptake in part to clinical decision tools built around population-level risk factors rather than individual imaging, cautious guideline processes and insurance reimbursement constraints. The March 2026 recommendation marks a change in the test’s place in guidance, but it does not by itself establish a new Medicare coverage rule.
The report describes CAC as one part of a broader prevention approach, not a replacement for clinical assessment. It also points to AI systems that may detect coronary or vascular calcification on existing CT images, including analysis of plaque types not captured by traditional calcium scoring. The authors say such tools could help expand risk assessment; the report provides no national adoption figures or outcome data establishing their effect on heart attacks.
“The guidelines have finally caught up to the evidence supporting coronary artery calcium scans.”
— Arthur Agatston, MD, and Oren Mechanic, MD, MPH, in their MedPage Today opinion report
heart healthy low sodium cookbook Mediterranean diet
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Coverage and Outcomes Still Need Clarity
The source does not specify whether Medicare covers CAC scans, what conditions might qualify for coverage, or how payment differs among Medicare, private insurance and patients paying directly. It also does not substantiate the headline’s $50,000 figure as a typical Medicare payment for a heart attack. The scan’s stated approximate price and the emergency-cost comparison should be read as figures used by the authors, not as a comprehensive analysis of costs.
It remains unclear how widely clinicians will use the updated recommendation, whether insurers will change coverage, and whether broader use of CAC testing will reduce heart attacks or overall spending. The report is an opinion piece, and its patient example does not resolve those questions. The authors’ discussion of AI-based plaque analysis also describes a developing approach without providing evidence here on its reach or impact on patient outcomes.
walking shoes supportive cushioned for daily exercise
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Guidance Must Meet Coverage
The immediate next step is for clinicians and patients to apply the updated guidance to individual cases where a preventive-treatment decision remains uncertain. Readers considering a scan should discuss their personal risk, possible results and costs with a healthcare professional; the article does not advise every adult to get one. Coverage decisions will depend on applicable Medicare and insurer policies, which are not detailed in the source report.
Whether the guideline change leads to broader access will depend in part on insurers, clinical practice and the development of systems that can use existing CT images to identify calcification. Evidence on adoption, coverage and patient outcomes will be needed to judge whether those changes make prevention more accessible or reduce heart attacks and costs.
Key Questions
What did the March 2026 guidelines change?
The ACC and AHA gave CAC scans a central role for adults at borderline or intermediate risk when the decision about preventive treatment remains uncertain.
Does Medicare pay for a CAC scan?
The cited report does not state whether Medicare covers the scan or set out coverage conditions. Patients should check current Medicare policy and ask their clinician or plan about costs.
What does a CAC score measure?
It measures calcified plaque in the coronary arteries. The report says the result can help refine a risk assessment, but it does not determine treatment on its own.
Does a score of zero mean there is no heart-disease risk?
No. The authors say a score of zero can reclassify risk downward, but the source does not claim it eliminates risk. Decisions should account for a person’s full clinical picture.
Is the $50,000 heart-attack figure a Medicare payment rate?
The source uses $50,000 as part of the authors’ comparison in an argument for prevention. It does not document that figure as a standard Medicare payment for a heart attack.
Source: rss
Evergreen bestsellers Picks
bestsellers
As an affiliate, we earn on qualifying purchases.
